Showing results (1011-1020 of 1,527) with videos related to

Sort By:
Pageof 153
Journal of Medical Genetics|October 1, 1988
Pathological features and prenatal diagnosis in the newly recognised limb/pelvis-hypoplasia/aplasia syndromeA Raas-Rothschild, R M Goodman, S Meyer, et al.
Pediatric Pulmonology|May 5, 2023
ATS Core Curriculum 2022. Pediatric Pulmonary Medicine: Updates in pediatric neuromuscular diseaseCarmen Leon-Astudillo, Caroline U A Okorie, Michael Y McCown, et al.
BMJ Open|July 13, 2017
A pilot randomised controlled trial of a periodised resistance training and protein supplementation intervention in prostate cancer survivors on androgen deprivation therapyJacqueline L Kiwata, Tanya B Dorff, E Todd Schroeder, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 3, 2010
[Evaluation of immediate breast reconstruction and radiotherapy: factors associated with complications]E Gross, J-M Hannoun-Levi, P Rouanet, et al.
The Journal of Arthroplasty|December 11, 2012
Total hip arthroplasty in Down syndrome patients: an improvement in quality of life: replacement arthroplasty in Down syndrome (RADS) study groupAllan E Gross, John J Callaghan, Michael G Zywiel, et al.
Journal of the American Chemical Society|February 19, 2010
Octafluorocalix[4]pyrrole: a chloride/bicarbonate antiport agentPhilip A Gale, Christine C Tong, Cally J E Haynes, et al.
Journal of the American Chemical Society|October 10, 2008
Enhanced anion exchange for selective sulfate extraction: overcoming the Hofmeister biasChristopher J Fowler, Tamara J Haverlock, Bruce A Moyer, et al.
Gynecologic Oncology Reports|August 20, 2025
Risk factors for delayed diagnosis of endometrial cancer among black individuals: Results from the GUIDE-EC studyMaya E Gross, Mindy Pike, Julianna Alson, et al.
Nature Communications|April 11, 2024
Multisensory flicker modulates widespread brain networks and reduces interictal epileptiform dischargesLou T Blanpain, Eric R Cole, Emily Chen, et al.
Frontiers in Oncology|August 14, 2023
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinomaChristopher Kwok, Adam Khorasanchi, Sarah P Psutka, et al.
Pageof 153